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to metabolism
Alice Nemajerova1, Ivano Amelio2, Jakob Gebel3, Volker Dötsch*,3, Gerry Melino*,2,4 and Ute M Moll*,1
The p53 family of transcription factors (p53, p63 and p73) covers a wide range of functions critical for development, homeostasis and
health of mammals across their lifespan. Beside the well-established tumor suppressor role, recent evidence has highlighted novel
non-oncogenic functions exerted by p73. In particular, p73 is required for multiciliated cell (MCC) differentiation; MCCs have critical
roles in brain and airways to move fluids across epithelial surfaces and to transport germ cells in the reproductive tract. This novel
function of p73 provides a unifying cellular mechanism for the disparate inflammatory and immunological phenotypes of p73-deficient
mice. Indeed, mice with Trp73 deficiency suffer from hydrocephalus, sterility and chronic respiratory tract infections due to profound
defects in ciliogenesis and complete loss of mucociliary clearance since MCCs are essential for cleaning airways from inhaled
pollutants, pathogens and allergens. Cross-species genomic analyses and functional rescue experiments identify TAp73 as themaster
transcriptional integrator of ciliogenesis, upstream of previously known central nodes. In addition, TAp73 shows a significant ability to
regulate cellular metabolism and energy production through direct transcriptional regulation of several metabolic enzymes, such as
glutaminase-2 and glucose-6 phosphate dehydrogenase. This recently uncovered role of TAp73 in the regulation of cellular
metabolism strongly affects oxidative balance, thus potentially influencing all the biological aspects associated with p73 function,
including development, homeostasis and cancer. Although through different mechanisms, p63 isoforms also contribute to regulation
of cellular metabolism, thus indicating a common route used by all family members to control cell fate. At the structural level, the
complexity of p73's function is further enhanced by its ability to form heterotetramers with some p63 isoforms, thus indicating the
existence of an intrafamily crosstalk that determines the global outcome of p53 family function. In this review, we have tried to
summarize all the recent evidence that have emerged on the novel non-oncogenic roles of p73, in an attempt to provide a unified view
of the complex function of this gene within its family.
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Facts
 Chronic respiratory tract infections of p73-deficient mice are
due to loss of mucociliary clearance as the result of severe
ciliary defects.
 TAp73 is essential for basal body docking and cilium
formation.
 TAp73 transcriptionally controls a host of key regulators and
structure/function genes critical for multiciliogenesis,
upstream of FoxJ1, Rfx2, Rfx3 and miR34bc.
 TAp73 controls key aspects of cellular metabolism to help
coping with stress.
 Ability to promote antioxidant defense is a central aspect for
cancer- and development-related functions of TAp73.
 p73 can form heterotetramers with p63 that are more stable
than the individual homotetramers.
 In healthy oocytes TAp63α forms closed, transcriptionally
inhibited dimers. DNA damage-mediated phosphorylation
rapidly activates its killing activity by enabling the formation
of active tetramers.
Open questions
 Is p73 involved in chronic obstructive pulmonary disease,
and how?
Graphical Abstract
1Department of Pathology, Stony Brook University, Stony Brook, NY 11794, USA; 2Medical Research Council, Toxicology Unit, Leicester University, Hodgkin Building,
Lancaster Road, PO Box 138, Leicester LE1 9HN, UK; 3Institute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt,
Germany and 4Department of Experimental Medicine and Surgery, University of Rome ‘Tor Vergata’, Rome 00133, Italy
*Corresponding author: G Melino or V Dötsch or UM Moll, Medical Research Council, Toxicology Unit, Leicester University, Hodgkin Building, Lancaster Road, PO Box 138,
Leicester LE1 9HN, UK. Tel: +44 116 252 5616 or +49 69 7982 9631 or +1631 444 2459; E-mail: gm89@le.ac.uk or vdoetsch@em.uni-frankfurt.de or
ute.moll@stonybrookmedicine.edu
Received 25.7.17; revised 12.9.17; accepted 18.9.17; Edited by F Pentimalli; published online 27.10.17
Cell Death and Differentiation (2018) 25, 144–153
Official journal of the Cell Death Differentiation Association
www.nature.com/cdd
 Is p73 function in airway multiciliogenesis associated with
its tumor suppressor role in lung cancer?
 Does TAp73-dependent metabolic regulation participate in
the multiciliogenesis process?
 Is there a specific function for p73/p63 heterotetramers?
P73 belongs to the p53 family of transcription factors.1 The
TP73 locus encodes two classes of isoforms, each under-
going further C-terminal exon splicing. The P1 promoter yields
TAp73 isoforms containing the N-terminal transactivation (TA)
domain.2 The P2 promoter yields N terminally truncated
isoforms (ΔNp73) that act as dominant-negative inhibitors of
p53/TAp63/TAp73. Both groups of isoforms can undergo
alternative splicings at the 3′ of the mRNA giving rising up to
seven different C-terminal informs, named α, β, γ, δ, ε, ζ and
η,3,4 which can be coexpressed or differently represented in a
tissue-specific manner.5 Although weaker than p53, TAp73 is
a tumor suppressor.6–8 Notably, aged TAp73-specific KO mice
(‘TAp73KO’, missing exons 2 and 3) develop lymphoma and
lung cancer,9 and in humans small-cell lung cancer is
characterized by recurrent rearrangements in TP73 leading
to oncogenic activation.10 However, p73’s primary role is in
development and homeostasis of specific tissues. Global
Trp73KO mice (‘p73KO’, replacing exons 5 and 6 with a
neomycin cassette), missing both isoform classes, exhibit a
mysterious and seemingly diverse phenotype that had been
lacking a clear cellular and molecular basis for many years.
In this review, we will discuss the recent evidence regarding
TAp73's contribution to cellular and organ development and
homeostasis. In particular, we will describe the newly
discovered role of TAp73 as the master regulator of motile
multiciliogenesis, with its associated implications for the
complex phenotype displayed by p73-deficient animal models.
We will then analyze the role of TAp73 in the regulation of
cellular metabolism in cancer and normal tissues in an attempt
to provide a unified view of the homeostatic roles of TAp73.
Finally, we will cover the structural aspects of TAp73
heterotetramerization properties, which carry important impli-
cations for TAp73 functions in different tissues and conditions.
TAp73 deficiency causes profound ciliogenesis defects
in airways
p73KO mice have severe hydrocephalus with cortical hypo-
plasia and hippocampal dysgenesis, and sensory vomerona-
sal abnormalities.2 One underlying cause for the grave brain
phenotype is the severely impaired self-renewal of neural
stem/progenitor cells during embryonic and adult
neurogenesis.11–14 However, this fails to fully explain the
severe hydrocephalus that these mice have. Moreover, p73
ablation also leads to runting, airway infections and female and
male fertility problems. Recently, four labs including ours
identified the unifying mechanism that explains these multi-
organ defects.15–18 While searching for a common underlying
theme to explain these disparate p73KO phenotypes, we
noticed a strong resemblance to human primary ciliary
dyskinesia (PCD) and mouse models of ciliopathies. This
allowed us to identify that p73 has a key role in motile
multiciliogenesis.
Cilia are highly conserved microtubule-based surface
organelles with essential functions in animal cells. Most
vertebrate cells can form a single, immotile primary cilium
that senses mechanical or chemical stimuli via Hedgehog
signaling. However, distinct epithelia – those lining airways,
brain ependyma, the female oviduct and the testicular efferent
duct – undergo multiciliogenesis by amplifying their centrioles
to nucleate hundreds ofmotile cilia per cell that beat vigorously
in a whip-like motion to generate directional fluid flow across
tissue surfaces. Thus, multiciliated cells (MCCs) are key
players in respiration, neurogenesis and fertility. The motile
cilium, composed of an axonemal 9+2 microtubular shaft with
dynein arms and anchored by a basal body (BB) at the apical
membrane, is a highly complex nanomachine with over 600
different proteins required for its assembly, structure and
function.19,20 Dysfunctional ciliogenesis underlie diverse
human diseases, including hydrocephalus, hippocampal
dysgenesis, PCD, Bardet–Biedl syndrome, asthma, anosmia,
chronic obstructive pulmonary disease (COPD) and sterility.
MCCs have crucial roles in the mucosal defense of
respiratory health, as they are essential for constantly cleaning
the airways from inhaled pollutants, pathogens, allergens,
dust and debris by a process called mucociliary clearance.
Conducting airways are lined by polarized pseudostratified
epithelium containing MCCs as well as secretory, goblet,
neuroendocrine and adult stem cells.21 Impaired mucociliary
transport caused by defective MCCs, either acquired or due to
genetic ciliopathies like PCD, results in chronic airway
infections, with airway remodeling and secondary alveolar
destruction causing emphysema and COPD.22
Focusing on airways, we found that all p73KO mice show
severe respiratory distress already by 3 weeks of age, with
constant coughing and sneezing due to chronic upper and
lower respiratory tract infections including purulent sinusitis/
rhinitis. Chronic bronchitis leads to bouts of pneumonia and
over time causes inflammation-mediated secondary tissue
destruction and lung emphysema. Isoform-specific TAp73KO
mice also develop similar airway pathology and impaired
pulmonary function. Wild-type (WT) epithelium strongly
expresses p73 in the nucleus of suprabasal MCCs character-
ized by long abundant cilial ‘brooms’ at their apical cell surface.
In contrast, p73KO and TAp73KO MCCs exhibit marked
reduction in cilia number and length (i.e. drastically fewer and
much shorter cilia) by light, electron and scanning microscopy
(Figures 1a–d). The defect encompasses the entire upper and
lower airways with the functional consequence of complete
loss of mucociliary transport.18 This severe ciliary phenotype
is also recapitulated in organotypic cultures, generated by
isolating tracheal progenitors and triggering their mucociliary
differentiation via air–liquid interface (ALI) conditions.23,24 This
also ensures that the ciliary phenotype seen in vivo is not
simply due to secondary effects of inflammation. In sum, p73 is
essential for the ciliation process in MCCs.
TAp73 transcription is required for MCC BB docking and
axonemal extension
Both mouse and analogous human tracheal epithelial cultures
(TECs) induce TAp73 expression early after ciliogenesis
initiation.18WhenMCCs are quantified for sequential stages of
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ciliogenesis,25 the early stages I and II of p73KO MCCs,
marked by centriolar amplification, appear relatively intact. In
contrast, marked defects progressively worsen during stages
III and IV. Final stage IV cells are strongly reduced, with
reciprocal increase in unciliated and early-stage arrested
cells. The largest reduction (by 90%) occurs in ‘fully ciliated’
cells, but even these have fewer and shorter cilia than WT
MCCs. While the number of BBs (the complex cilial anchoring
structures at the apical surface) is relatively intact, p73KO BBs
show severe docking defects and fail to properly align at the
apical membrane, and therefore are unable to extend
axonemes. Overall, this indicates that p73 mainly functions
after MCC fate specification and centriolar multiplication as the
major upstream ciliogenesis regulator orchestrating BB dock-
ing, axonemal extension and motility.
Next, we compared RNA-seq expression profiles from WT
and p73KO ALI cultures across differentiation with human
TAp73 ChIP-seq data. This yielded a total of 1930 genes
falling into three categories of (1) differentially expressed (DE)
genes, (2) DE genes containing TP73-binding motifs and (3)
bound DE genes containing a p73 motif in promoter/enhancer
regions. Gene Ontology analysis showed significant enrich-
ment of ciliogenesis genes, in fact, 12% of all 1236 DE genes
at day 14 (full differentiation). The vast majority of these 155
ciliogenic genes are downregulated in p73KO, indicating a
transactivating function for TP73. Fifty-two cilium DE genes
are bound by TAp73 and contain the highly conserved TP73-
binding motif (category 3). They include the key ciliogenic
transcriptional regulators FoxJ1, Rfx2, Rfx3 and Myb,19,26 and
the regulatory microRNAmiR34bc that enables BB docking.27
Moreover, nearly 50 key structural and functional ciliary genes
associated with intraflagellar transport, transition fibers, BBs,
planar cell polarity and motility (with many dynein motor
genes) are also among them. Eight of these genes are known
to cause hereditary human ciliopathies when mutated
(Figure 2, genes highlighted in red).
Finally, we asked howTAp73 itself might be regulated during
multiciliogenesis and identified Mcidas (aka Multicilin), using
comparative genomic analysis of published data sets.
Previous work identified Multicilin, a small coiled-coil tran-
scriptional coregulator, to be required for the initial stages of
MCCdifferentiation. It binds to E2F4/5 to promote transcription
***
n.s.
Figure 1 Selective absence of p73 in mice results in severe abnormalities of ciliogenesis in the airways. (a) Transmission electron microscopy and (b) scanning electron
microscopy of the trachea of p73 knockout (p73KO) and control (WT) mice at 2 months of age. The p73-deficient mice show highly defective, rare, short, stump-like cilia (arrow).
Asterix, microvilli. TAp73KO mice have a similar phenotype. (c) Measuring mucociliary transport. Aggregated fluorescent bead trajectories in control (WT) versus TAp73KO
tracheae. WT trajectories (red arrow) follow a directional flow field that is completely lost in knockout tracheae. (d) Distribution of particle velocities (measured as μm/s) from WT,
TAp73KO and WT diffusion control (formalin-fixed) tracheae as in panel c. (e) Proposed role of TAp73 as master transcriptional regulator of motile multiciliogenesis in airways,
directly controlling Fox, Rfx2/3, Myb and miR34, plus a plethora of ciliary structure/motility genes. Mcidas is upstream of TAp73. Modified with permission from Nemajerova et al.,
2016. Asterix indicates genes directly regulated by TAp73. n.s. nonsignificant
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of key genes in centriole biogenesis.28,29 In support, ectopic
expression of Mcidas in WT ALI culture at day 0 rapidly
induced TAp73 expression, and reporter assays confirmed the
direct Mcidas/E2F4 responsiveness of the TAp73 promoter
(Figure 1e).
TAp73 is necessary and sufficient to drive the full
multiciliogenesis program
Finally, to prove that TAp73 alone, rather than in cooperation
with ΔNp73, is necessary and sufficient to fully direct
ciliogenesis, we performed rescue experiments in global
p73KO (missing both isoform classes) ALI cultures. Indeed,
lentiviral TAp73α, expressed in MCC-fated cells, completely
rescued cilia biogenesis. Also, to establish that TAp73 lies
upstream of all currently known transcriptional activators, we
performed epistasis analyses for FoxJ1, given its essential
role in the multiciliogenesis hierarchy. Indeed, the severe
defect of global p73KO ALI cultures were 100% rescued by
lentiviral FoxJ1 expression restricted to MCCs.18
In sum, our results place TAp73 at the center of the gene-
regulatory network controlling multiciliogenesis (Figure 2).
Mechanistically, TAp73 directly activates key transcriptional
and post-transcriptional regulators, most notably FoxJ1, Rfx2,
Rfx3, Myb and miR34bc, as well as numerous structural and
functional ciliogenesis genes. Our data further suggests that
Mcidas regulates TAp73 in this process. This regulatory
network is conserved between mouse and human.18
Two labs, focusing on ependymal biology, corroborated our
findings. Using morphologic analysis of p73KO brains, they
described cilial denudation of ependymal cells plus disorga-
nization of the neurogenic niche cytoarchitecture (’pin-
wheels’), which lies directly underneath the ependymal
layer.15,17 Specifically, p73 deficiency impairs maturation,
planar cell polarity and ciliogenesis of ependymal cells and
thereby disturbs the neurogenic capacity of the subventricular
zone.15
Moreover, a direct link between p73 and FoxJ1 was also
independently identified by the Pietenpol lab.16 The authors
found defects in p73-deficient multiciliated cells in the upper
and lower respiratory tract, ependyma, oviduct and testis and
used a ChIP-seq/RNA-seq approach on mouse tracheas to
identify a broad p73-dependent ciliogenic program. And
similar to our observations, ectopic TAp73β expression in
mouse TEC cultures induced FoxJ1 expression. Interestingly,
using co-immunofluorescence these investigators also
described a subset of p63-positive basal cells to coexpress
p73, raising the possibility that p73 might also have some role
in MCC fate specification and maintenance of the basal stem
cell pool.16 More work is needed to resolve the meaning of this
double-positive sub-population in tracheal epithelium. Now
that TAp73 is the new master regulator of motile multi-
ciliogenesis, future work will also need to clarify whether
ΔNp73 has a role in ciliated epithelium, and if so, define its
nature and whether or not it cooperates with TAp73 in cilial
biology.
The p53 family members in the control of cellular
metabolism
The p53 family is well known for its tumor suppressor role that,
to a different extent, is exerted by the full-length isoforms of all
family members. Similar to p53KO mice,30 although only to a
moderate degree, mice lacking TAp73 also develop sponta-
neous tumors9 and display increased susceptibility to
chemical-induced carcinogenesis.9,31 Lack of TAp63 isoforms
Figure 2 TAp73 is a crucial transcriptional regulator of multiciliogenesis. Scheme of cilium (left) and direct target genes of TAp73 in ciliogenesis (right). Genes were identified
by RNA-seq analysis of WT versis TAp73KO airway cultures during MCC differentiation, combined with ChIP-seq analysis in TAp73α/β-expressing Saos-2 cells. In addition to
central ciliogenic transcription factors and regulatory miR34bc, key structural and functional ciliary genes of every category including eight human PCD-associated genes
indicated in red are among them. Modified with permission from Nemajerova et al., 2016. IFT, intraflagellar transport; MTs, microtubules
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has been associated with increased metastatic propensity of
cancer cells, leading to the proposal of TAp63 as a tumor
metastasis suppressor.32–34 All three family members, p53,
TAp73 and TAp63, react to DNA damage, and upon severe or
sustained genotoxicity promote cell death or senescence.35
These responses represent an effective barrier to eliminate
damaged cells, thus limiting the inappropriate accumulation of
cells that might initiatemalignant development. In conditions of
mild or short-term stress, p53 family members rather exert a
repair response such as DNA repair or antioxidant defense to
limit damage and restore physiological cell activity. Metabolic
stress, nutrient or oxygen deprivation enable a p53 family-
mediated adaptive response, in which metabolic adaptation
and rebalancing of anabolism/catabolism coordinate a
response to cope with such adverse conditions. While in
physiologic conditions these functions preserve cellular and
organ integrity, in cancer they might contribute to the
development of the disease and to reduced therapeutic
responses.
The dynamic, flexible and adaptable stress responses by
p53 family members highlight the general complexity of the
tumor suppressor mechanisms. However, they also suggest a
rationale for the observed overlap between the contribution of
these genes to the control of tumor development and to the
maintenance of normal cellular homeostasis and organ
development, such as multiciliogenesis. This is particularly
remarkable for the p63 and p73 genes, which exert pivotal
developmental functions. The contribution of TAp73 and the
N-terminal truncated isoform of p63 (ΔNp63) to ciliogenesis
and epidermal development, respectively, might indeed
partially rely on their ability to control cellular metabolic
homeostasis. Hence, conserved molecular mechanisms in
different biological contexts lead to different outcomes. In this
section, we will summarize the recent findings on p63 and p73
control of cellular metabolism, with a particular focus on
glucose metabolism. We will also discuss the contribution of
these processes to developmental and tumor-related func-
tions of this gene family.
TAp73 coordinates metabolic response with oxidative
stress and amino-acid deprivation
Glucose represents a major source of carbon and energy for
mammalian cells. Thus, glycolysis is a critical metabolic
pathway for virtually any cell type in physiological conditions
and in disease. Cancer cells tend to rewire their metabolism,
strongly increasing the rate of the glycolytic flux and
converting the final product pyruvate to lactate rather than to
acetyl-CoA. This shift produces what is defined as ‘aerobic
glycolysis’ or ‘Warburg effect’ and is typically associated with a
reduced tricarboxylic acid cycle (TCA) and thus much less
efficient energy production. Despite the apparent poor ATP
efficiency, this shift is important for cancer cells to refuel
diverting anabolic pathways (Figure 3). Recent evidence
suggests an expected role of TAp73 in promoting glycolytic
flux.36,37 High-throughput metabolomics in SaOs-2 human
osteosarcoma cells unveiled increased rates of glycolysis,
higher amino-acid uptake and increased levels and biosynth-
esis of acetyl-CoA following TAp73 overexpression. Remark-
ably, this metabolic shift correlated with an extensive TAp73-
mediated upregulation of several anabolic pathways including
for serine and glycine (SG),38 polyamine and the biosynthesis
of membrane phospholipids.36,37 Although apparently contra-
dictory with the tumor suppressor role of TAp73, this metabolic
effect does not really recapitulate the canonical cancer-
associated metabolic changes, but rather suggests a role for
TAp73 in promoting adaptive cellular mechanisms to stress
conditions. In fact, the TAp73-dependent increase in glycolytic
flux was also associated with an increase in both lactate and
TCA cycle intermediates, indicating that TAp73 overexpres-
sion favors a general promotion of glucose metabolism
towards production of energy and activation of anabolism.
One of the major aspects of TAp73's influence on cellular
anabolism is its ability to promote SG biosynthesis.38 Serine
represents a cellular metabolic hub, which provides precur-
sors for the biosynthesis of amino acids, nucleic acids, lipids,
ATP and antioxidative defense.39 Hyperactivation of SG
biosynthesis and overexpression (amplification) of the respec-
tive metabolic enzymes are indeed observed in cancer.40,41
TAp73 promotes synthesis of SG producing metabolic
intermediates required for glutathione (GSH) production and
therefore antioxidant defense. Interestingly, TAp73 deficiency
sensitizes cells to SG deprivation, effectively creating a
vulnerability in cancer cells. Mechanistically, TAp73 promotes
expression of glutaminase-2, which converts glutamine to
glutamate, which in turn promotes SG biosynthesis. Notably,
both glutamate and glycine represent substrates for GSH
synthesis. Thus, upon SG starvation TAp73 deficiency
prevents a response for restoring proper antioxidant defense,
resulting in proliferation arrest. Effectively, in these specific
conditions the tumor suppressor TAp73 favors adaptation of
cancer cells to adverse condition. A role for TAp73 in
antioxidant response has also been reported by other studies.
TAp73 also regulates glucose metabolism to control the
pentose phosphate pathway (PPP) and antioxidant
capacity.37,42 The PPP pathway is equally important for the
antioxidant response, as NADPH produced in this pathway is
required to regenerate reduced GSH.43 TAp73 transcription-
ally promotes expression of the rate-limiting enzyme of PPP,
glucose-6-phosphate dehydrogenase (G6PD). Remarkably,
the proliferation arrest produced by TAp73 depletion can be
restored by G6PD re-expression or by treatment with
antioxidants such asN-acetylcysteine.42 Thismajor regulatory
role of TAp73 does not clash with its tumor suppressor ability,
but rather represents a physiological protective mechanism
exerted by TAp73. TAp73 deficiency indeed correlates with
premature senescence and accelerated ageing in mice as a
consequence of alteredmitochondrial function and antioxidant
balance.44 TAp73 transcriptionally controls the expression of
mitochondrial complex IV subunit cytochrome C oxidase,
subunit 4 (Cox4i1). Thus, TAp73 deficiency results in reduced
cellular ATP levels, oxygen consumption and mitochondrial
complex IV activity, with increased ROS production and
oxidative stress sensitivity. Overall this leads to premature
ageing of TAp73KO mice and accelerated senescence of
TAp73KO MEFs. Importantly, this last phenotype can be
reverted by a combination of antioxidants.44 This homeostatic
role of TAp73 in regulating antioxidant defense preserves cells
from premature senescence and might produce a vulnerability
in cancer cells. This represents an instance in which the
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cancer cell hijacks a physiological protective function of a
tumor suppressor gene. However, the role of TAp73 in
regulating cancer metabolism has not been fully dissected
yet and the scenario might be much more complex than what
has been revealed so far, considering also the interplay of
TAp73 with other pathways such as HIF-1 signaling.31,45
TAp73 also exerts pivotal and exclusive roles in develop-
ment. It is indeed remarkable that both p73KO and selective
TAp73KO mice display severe morphological defects in the
central nervous system, such as cortex hypoplasia and
hippocampal dysgenesis.2,9 Several mechanisms have been
ascribed to p73's role in the brain; however, whether and how
metabolic effects are responsible for this is still under
investigation. Metabolomics analysis of TAp73KO and
ΔNp73KO primary cortical neurons indicated that TA and ΔN
isoforms have opposite effects on glycolytic pathways and
mitochondrial respiration in neurons.46 However, the molecu-
lar basis for these effects and the contributions of p73-
dependent metabolic changes to development and home-
ostasis such as neurodevelopment and multiciliogenesis will
require further studies.
Cellular metabolism is also controlled by p63 in
epidermal development
Similarly to TP73, TP63 gene gives rise to a wide number of
isoforms, which include N-terminal alternative transcribed
isoforms (TAp63 and ΔNp63) and C-terminal alternative
spliced proteins (α, β and γ). A major aspect in development
is the key function of the N terminally truncated isoform of p63
(ΔNp63) in stratified epithelial morphogenesis and home-
ostasis. Expression of ΔNp63 is critical for maintenance of
stem cell-like properties and high proliferative status in basal
keratinocytes. Control of cell cycle, cell adhesion and other
mechanisms have been ascribed to this role.47 However,
recent emerging evidence indicates a specific requirement for
ΔNp63 for maintenance of an active metabolic status of
proliferating keratinocytes (Figure 3). Depletion of ΔNp63 in
human proliferating keratinocytes indeed leads to reduction of
glycolytic rate and mitochondrial respiration.48 Altered mito-
chondrial function of ΔNp63-depleted keratinocytes is asso-
ciated with mitochondrial hyperpolarization and increased
intracellular ROS. Mechanistically, Viticchie et al.48 demon-
strated that ΔNp63 physically binds to the hexokinase II (HK2)
promoter and thus induces its transcriptional activation. The
hexokinase family includes four isoforms that catalyze the first
step of the glycolytic pathway converting glucose to glucose-6-
phosphate. The preferential mitochondrial membrane locali-
zation of HK2 at voltage-dependent anion channels provides
access to ATP generated by oxidative phosphorylation.
Impairment of HK2 therefore might result in alteration of
ADP/ATP turnover, impairment of the respiratory chain and
electron leak. ΔNp63-depleted keratinocytes could restore
their proliferation ability upon re-expression of HK2. Control of
the keratinocyte glycolytic flux by ΔNp63 was confirmed in a
second study, and this was associated with transcriptional
regulation of 6-phosphofructo-2-kinase/fructose-2,6-bipho-
sphatase 3, a dual enzyme with a 6-phosphofructo-2-kinase
Figure 3 Influence of p73/p63 on the major metabolic pathways. P63 and p73 both promote a general increase in glucose catabolism, resulting in an increase in diverting
anabolic pathways and mitochondrial respiration. Activation of serine biosynthesis and the PPP by TAp73, ΔNp63 and TAp63 facilitates the antioxidant response through
increased synthesis of GSH and regeneration of reduced GSH. Conversely, a reduced function of TAp73 and ΔNp63 negatively influences mitochondrial respiration, leading to
electron leaks and oxidative stress. Overall, p53 family member function on cellular metabolism appears a critical process for maintaining the cellular redox balance, which has
important implications for a number of different biological processes in tumor suppression, stress response and development. GSSG, oxidized GSH
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activity catalyzing synthesis of fructose-2,6-bisphosphate
(F2,6BP) and a fructose-2,6-biphosphatase activity catalyzing
the degradation of F2,6BP. PFKB3 is a major regulator of
glycolysis; F2,6BP indeed acts as an allosteric activator of
phosphofructokinase 1 (PFK1), themajor rate-limiting enzyme
of glycolysis. Hence, the ΔNp63/PFKB3 axis determines the
rate of activation of glycolytic flux, thereby tuning the
proliferation potential of basal keratinocytes. Aberrant expres-
sion of PFKB3 was indeed found in skin hyperproliferative
conditions such as psoriatic epidermis, although the current
data do not clarify whether accumulation of PFKB3 is
causative of the pathological conditions or a simple conse-
quence of the expansion of the proliferative compartment.
Remarkably, these data all together indicate that in different
cellular and biological contexts, the p53 family conserves this
critical role of maintaining a healthy cellular oxidative balance.
This function is also displayed by TAp63 whose activation
promotes glycolytic flux and a slightly reduced TCA flux,
thereby diverting glycolytic intermediates to anabolic path-
ways such as PPP and SG.49 The result of this metabolic
control by TAp63 is again increased biosynthesis and
regeneration of cellular GSH, which might have pivotal roles
in different biological contexts.
Other non-oncogenic functions of p73: fertility,
neurodevelopment and inflammation
The complexity of p73 functions clearly emerges from the
phenotypes of the KO mouse models, which show a range of
defects that include infertility, an altered immune system and
impaired neurological development. The control of genomic
stability is central to all family members, and the genomic
instability associated with TAp73 deficiency is not only
important in tumorigenesis but also influences maturation of
oocytes. In addition to cilia-deprived oviducts with severe
transport defects, altered segregation of sister chromatids
during meiosis leads to poor quality eggs and consequent
female infertility. TAp73 controls the spindle assembly
checkpoint (SAC) that prevents aberrant anaphase by inhibit-
ing its onset until all chromosomes are properly attached to the
spindle. SAC blocks progression of the cell cycle by inhibiting
CDC20 and the anaphase-promoting complex. This guaran-
tees a correct segregation of the sister chromatids. TAp73
physically binds to kinetochore proteins BUB1, BUB3 and
BUBR1, allowing correct entry into anaphase.9,50 Deregula-
tion of this process in oocytes contributes to infertility: TAp73
deficiency in oocytes and cancer cells is indeed associated
with aneuploidy.51 Similar to females but following a different
mechanism, TAp73KO males also display reduced fertility.
Seminiferous tubules of TAp73KO mice have indeed massive
premature loss of immature male germ cells. The defect in
sperm maturation is due to impaired cell–cell adhesion
properties between developing germ cells and somatic Sertoli
nurse cells. Mechanistically, TAp73 controls a transcriptional
program in male germ progenitors that governs orderly
spermatogenesis within the multilayered germinal
epithelium.52,53
Originally, the reduced fertility of the p73KO genotype was
interpreted as defects in sensory and hormonal pathways
contributing to behavioral phenotypes that preclude mating.2
However, this mechanism was later disproven, as TAp73KO
mice displaying normal sensory and hormonal abilities still
present with severe infertility.9,54 However, alterations in
sensory and hormonal pathways are part of the wide range
of neurological defects displayed to different degrees by the
Trp73KO mouse models. Anatomically, p73KO mice display
severe hydrocephalus and hippocampal dysgenesis charac-
terized by an unusual structural organization of the CA
Summer sectors and the dentate gyrus (DG). TAp73KO mice
display a less severe phenotype, but abnormal hippocampal
development (truncation of the lower blade of the DG) still
occurs. However, reduced cortical thickness and hydrocepha-
lus is specific for p73KO mice, indicating that the concurrent
loss of all TAp73 and ΔNp73 isoforms produce a much more
severe phenotype than the addition of the individual pheno-
types of the isoform-selective KOmodels. ΔNp73 mice indeed
display only a marginal reduction of cortical thickness but no
hydrocephalus.55
Different mechanisms underlying p73's contribution to
neuronal development have been described. A general
consensus exists on the role of TAp73 in the maintenance of
embryonal and adult neural stem cells. TAp73KO neuro-
spheres display defects in growth, associated with S-phase
block and accelerated cellular senescence. Accordingly, p73-
deficient mice (p73KO and TAp73KO) have significant deple-
tion of stem cell reservoirs in the subgranular and subven-
tricular zones.11–14,56 TAp73 deficiency also impairs neuronal
differentiation. p73KO neuronal stem cells fail to fully
differentiate and exhibit dendritic arborization and reduced
synaptic connectivity. In this context, miR-34a appears to be a
major transcriptional target of TAp73 for neuronal differentia-
tion. In vivo evidence indicates a significant contribution of the
TAp73/miR-34a axis to the neurological phenotype of p73
mouse models,57 and miR-34a KO mice likewise show
significant reduction of precursors in the DG and subgranular
zone.58,59 However, the recent establishment of a role for
TAp73 in governing ciliogenesis leads to a revision of the
biological and molecular aspects underlying the fertility and
neurological phenotypes of p73KO mice.
The influence of TAp73 on the immune response has been
the focus of some studies, but how important its contribution is
in the response to pathogens and cancer immunity remains to
be determined. TAp73 has a role in macrophage polarization,
as TAp73 deficiency prolongs maintenance of the M1 effector
phenotype at the expense of the M2 phenotype. Altered M1/
M2 macrophage polarization impairs the resolution of an
inflammatory response. Indeed, lethal doses of lipopolysac-
charide in TAp73KO mice leads to higher blood levels of
proinflammatory cytokines and lethality.60 The original p73KO
mouse showed recurrent infections, such as severe rhinitis
and purulent otitis media. Massive neutrophil infiltrations are
persistent from young age through adulthood in these
anatomical sites, leading to chronic, bilateral rhinitis, otitis,
periorbital edema and conjunctivitis. However, despite these
signs of severe inflammation and infection, lymphoid or
granulocyte populations appear normal in p73KO mice.2
Whether and how the altered macrophage polarization
worsens the recurrent airway infections in p73KO and
TAp73KO mice with their defective mucociliary clearance
remains to be determined.
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Complex interplay between p73 and the other family
members: structural insights
All three members of the p53 family share a highly conserved
DNA-binding domain that is the basis for a significant overlap
in target genes and functional redundancies. Moreover, the
complexity of biological functions in this family is further
enhanced by the formation of oligomers. All family members
can form tetramers through a highly conserved oligomeriza-
tion domain. The architecture of this oligomerization domain is
very similar between p63 and p73,61,62 but differs from the
oligomerization domain of p53. In vitro experiments with the
isolated oligomerization domains have demonstrated that p63
and p73 form stable hetero-oligomers, while neither interacts
with p53.61,62 Surprisingly, a heterotetramer consisting of one
p63 dimer and one p73 dimer is more stable than the two
individual homotetramers. Structure determination of a
heterotetramer of two p63 and two p73 molecules elucidated
the basis for this interaction, revealing additional hydrophobic
contacts that stabilize the heterotetramer63 (Figure 4). A
potential specific function for the heterotetramer requires cells
that coexpress both p63 and p73. Immunostainings of skin of
5-day-oldmice (P5) has indeed shown that in the basal layer of
the epidermis and in the outer root sheath (ORS) of hair
follicles double-positive cells exist.63 While more cells in the
basal layer and hair follicles show strong p63 expression, p73
expression seems to be confined to a smaller number of cells.
In primary human keratinocytes, again strong p63 expression
but only weak p73 expression can be detected, which however
can be increased upon differentiation using high concentra-
tions of calcium.64 Co-immunoprecipitation experiments
revealed that in these coexpressing keratinocytes heterote-
tramers are formed.63 The existence of heterotetramers bound
to DNA has also been suggested by a genome-wide mapping
of p63 and p73 target sites in ME180 human cervical
carcinoma cells.65 This study has revealed that the binding
profile for p73 is indistinguishable from a previously deter-
mined binding profile of p63 in the same cell type.66 Sequential
chromatin immunoprecipitation experiments further sug-
gested that p63 and p73 co-occupy DNA target sites, arguing
for the formation of heterotetramers in vivo.
Coexpression of p63 and p73 has also been reported in
head and neck squamous cell carcinoma cells, a group of
tumors derived from the basal epithelia of the aerodigestive
mucosa.67 These cancer cells are characterized by high levels
of the ΔNp63α protein.68 Interaction studies have shown that
ΔNp63α interacts directly with transcriptionally active TAp73β,
and that the transcriptional and tumor suppressor activity of
this p73 isoform is inhibited by overexpression of ΔNp63α.67 In
these cells, p63 knockdown leads to apoptosis through the
expression of PUMA and NOXA. Further mechanistic studies
have suggested, however, that the inhibitory effect is most
likely caused by direct competitive binding of ΔNp63α to
promotor sequences rather than by its binding to TAp73β
protein.63
Interactions between p63 and p73 can in principle occur
with all isoforms, with the exception of TAp63α. This isoform is
very highly expressed in primary oocytes that are arrested in
meiosis I54 in the ovary, as well as in fibronectin-positive
dermal sheath cells of the hair follicle, in a sub-population of
NCAM-positive dermal papillae cells69 and in hepatocytes
where its overexpression induces liver steatosis through
activation of IKKβ.70 In healthy oocytes TAp63α forms closed,
transcriptionally inhibited dimers71 through the formation of a
β-sheet between the N-terminal transactivation domain and
the C-terminal transactivation inhibitory domain with the
central oligomerization domain.72 In contrast to TAp63α,
TAp73α forms an open tetramer despite high sequence
identity with TAp63α including the N- and C-terminal
domains.73 Upon DNA damage, the activity of TAp63α is
regulated by kinases that phosphorylate74 and open the
closed inhibited dimeric state, thereby allowing the formation
of active tetramers that eliminate the damaged oocyte.72 For
p73, different transcriptional activities of individual C-terminal
splice variants have been reported.3 However, these different
C termini do not seem to regulate their activity by modulating
their oligomeric state.73 Instead, differential recruitment of
Figure 4 Tetramerization model of the p63/p73 interaction. (a) Heterotetramer-
ization between p63 and p73 isoforms is possible in tissues where both proteins are
coexpressed in the same cells at the same time. Squamous cell carcinomas express
high levels of ΔNp63α as well as TAp73. The proapoptotic function of TAp73 seems
to be repressed by the high abundance of ΔNp63 via promoter squelching, as
knockdown ofΔNp63 leads to expression of Puma/Noxa with subsequent apoptosis.
In basal keratinocytesΔNp63α is also expressed at high levels. During differentiation
a short burst of p73 expression can be observed. In addition, p63/p73 colocalization
can be observed in some cells of the basal layer of the epidermis and the ORS of hair
follicles of mouse skin. (b) Isoforms of p63 and p73 that are available for
heterotetramer formation. P73 is a constitutive tetramer; therefore, all isoforms can
participate in heterotetramer formation. In contrast, inactive TAp63α is a closed dimer
with a buried tetramerization domain. All other p63 isoforms either lacking the
N-terminal TA domain (ΔN isoforms) or the C-terminal inhibitory domain (TID,
isoforms β, γ, δ and ε) are tetramers and therefore can participate in heterotetramer
formation
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cofactors and other proteins that modulate their transcriptional
activity at specific promoter sites, as well as differential
intracellular stability might be mechanisms determining how
p73's activity is regulated, derived from a combination of
concentrations of its different splice forms and post-
translational modifications.5,75,76
Concluding remarks
The importance of the p53 family for tumor suppression has
been thoroughly established during the past few decades, but
the rapid development of several mouse models has also
highlighted pivotal non-oncogenic roles for all family members,
in particular for TAp63α, ΔNp63 and TAp73. The recent
discovery of TAp73 as themaster regulator of multiciliogenesis
has opened alternative explanations for some long-standing
perplexing questions in the field, as a molecular and biological
foundation for the immunological, neurological and reproduc-
tive phenotypes displayed by p73-deficient mouse models.
Together with the identification of critical roles in regulating
cellular metabolism, this discovery has also layed open a
substantial number of novel biological problems that might
have important implications for human health. It will be critical
to now investigate whether the p73-dependent defects in
airway ciliogenesis are associated with human pathological
conditions such as COPD or lung cancer. Indeed, the
distinction between tumor-suppressive and non-cancer roles
of TAp73 might not be as sharp and a wide overlap of similar
functions in different contexts could be responsible for distinct
phenotypes. This is particularly evident in the regulation of
cellular metabolism, where for example the homeostatic
control of physiological oxidative balance might have a role
during cancer transformation or even, paradoxically, favor
cancer progression in later stages of the disease. Another
important aspect that recently emerged is the intrafamily
interplay, with the ability of p63 and p73 to form genome-wide
heterotetramers bound to DNA. The function of these two
members might indeed need to be investigated globally, as the
study of the two genes individually could provide only a
restricted view of their complex functions.
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